Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Critical Reviews in Oncology/Hematology|July 13, 2024
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to successLorenzo Belluomini, Alice Avancini, Marco Sposito, et al.
Asia-Pacific Journal of Oncology Nursing|January 10, 2024
Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancerAlice Avancini, Anita Borsati, Ilaria Trestini, et al.
Expert Review of Anticancer Therapy|June 13, 2020
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectivesGiulia Sartori, Lorenzo Belluomini, Fiorella Lombardo, et al.
Recenti Progressi in Medicina|January 22, 2026
[CHALLENGE accepted! Exercise in oncology: from "Supportive Care" to "Effective Treatment".]Aureliano Stingi, Giuseppe Aprile, Sara Aspromonte, et al.
The Oncologist|March 13, 2020
Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled?Alice Avancini, Giulia Sartori, Anastasios Gkountakos, et al.
Critical Reviews in Oncology/Hematology|April 20, 2024
What is the role of physical exercise in the era of cancer prehabilitation? A systematic reviewNicole Del Bianco, Anita Borsati, Linda Toniolo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 13, 2026
Current practices, barriers and facilitators toward simultaneous care management in patients affected by pancreatic adenocarcinoma: An Italian cross-sectional surveyIlaria Trestini, Alice Avancini, Valentina Da Prat, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 24, 2021
Exercise prehabilitation in lung cancer: Getting stronger to recover fasterAlice Avancini, Alessandro Cavallo, Ilaria Trestini, et al.
International Journal of Molecular Sciences|March 28, 2026
Oligoprogression in NSCLC with Other Actionable Oncogenic Drivers Beyond EGFR and ALK: An Emerging EntityIlaria Mariangela Scaglione, Adele Bonato, Alessandra Dodi, et al.
Pageof 9